1057 studies found for:    multiple sclerosis.
Show Display Options
Rank Status Study
21 Active, not recruiting Exploratory Study to Assess the Effect of Fampridine on Walking Ability and Balance in Patients With Multiple Sclerosis.
Condition: Multiple Sclerosis
Interventions: Drug: PR Fampridine;   Other: Placebo
22 Recruiting Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: Disease Modifying therapy
23 Enrolling by invitation Progression of Cognitive and Physical Symptoms in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
24 Unknown  Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
25 Completed Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Simvastatin;   Drug: Placebo
26 Unknown  A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
27 Unknown  Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: Physical exercise training
28 Recruiting Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: PET with 11C-Flumazenil
29 Completed
Has Results
A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis
Conditions: Multiple Sclerosis;   Neuropathic Pain
Interventions: Drug: Placebo;   Drug: Sativex
30 Completed
Has Results
A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo
31 Recruiting A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: AIN457
32 Completed
Has Results
A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
Conditions: Detrusor Overactivity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
33 Completed Study Assessing the Interaction of Pantoprazole With Cladribine in Subjects With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Cladribine;   Drug: Cladribine and Pantoprazole
34 Completed Study Evaluating CCI-779 in Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: CCI-779
35 Completed Depression and Fatigue in MS Patients Treated With Betaferon.
Condition: Multiple Sclerosis
Intervention: Biological: Interferon beta-1b (Betaferon, BAY86-5046)
36 Completed Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b
Condition: Multiple Sclerosis
Interventions: Drug: Interferon beta 1b;   Drug: Atorvastatin
37 Terminated MUltiple Sclerosis and Extract of Cannabis (MUSEC) Study
Condition: Muscle Spasticity
Interventions: Drug: standardized cannabis extract;   Drug: Placebo
38 Terminated Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)
Conditions: Multiple Sclerosis;   Bladder Dysfunction
Intervention: Drug: Alfuzosin
39 Completed Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Nerispirdine (HP184);   Drug: placebo
40 Recruiting Complementary and Alternative Care in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years